Elongation and termination of transcripts by RNA pol II
RNA pol II 转录本的延伸和终止
基本信息
- 批准号:8604397
- 负责人:
- 金额:$ 30.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectBiochemicalBiological AssayBurkitt LymphomaCell SurvivalCellsChromatinComplexCoupledDNA Polymerase IDNA-Directed RNA PolymeraseDNA-dependent ATPaseDevelopmentDiseaseDistalDrosophila genusElongation FactorExonucleaseFundingGene ExpressionGenesGeneticGenetic ScreeningGenetic TranscriptionHIVHeat-Shock ResponseHumanHypoxia Inducible FactorInheritedInvestigationLinkMYC geneMalignant NeoplasmsMammalian CellMessenger RNAModelingMutationNucleosomesPhasePhosphorylationPoly APolymerasePositioning AttributeProcessProteinsRNARNA Polymerase IRNA Polymerase IIRecyclingRegulationRoleSaccharomycetalesSignal TransductionSiteStimulusSyndromeTestingTorpedoTranscriptTranscription CoactivatorTranscription ElongationTranscription Initiation SiteTranscriptional RegulationWorkattenuationbasec-myc Genesin vivooverexpressionprematurepreventprogramspromoterpublic health relevanceresponsesmall hairpin RNAtermination factortranscription factortranscription termination
项目摘要
DESCRIPTION (provided by applicant): The control of gene expression through regulated transcription by RNA polymerase I (pol II) is fundamental to the cell viability and is often corrupted in disease. The transcription cycle comprises initiation, elongation and termination phases. This proposal focuses on the latter two steps because the mechanisms that govern them are less well elucidated than initiation. Our lab uses strategies that combine genetics to make mutations in pol II and elongation factors with biochemical assays of elongation and termination in vivo using budding yeast and mammalian cells. Termination is required to recycle the RNA polymerase and to prevent interference between adjacent genes but the mechanism that triggers disassembly of the extremely stable transcription elongation complex at the end of genes is quite incompletely understood. We will investigate this mechanism by asking how it is affected by pol II phosphorylation and transcription elongation rate. We will also look for new players in termination by using two approaches: 1) a candidate approach based on our identification of protein factors that interact with the termination factor Xrn2, an RNA exonuclease and 2) an unbiased genetic screen for shRNA that inhibit termination. We will also test a model we recently proposed for control of elongation by premature termination that we call the "decap and torpedo" model. This model suggests that the flux of pol II from the pause site at the beginning of most human genes into the gene body is limited by decapping of the transcript and subsequent premature termination of transcription by Xrn2 and associated factors. We will test the details of this model and ask whether decapping and termination factors function in regulation of the elongation phase of the transcription cycle. We will focus on the potential role of decapping and termination factors in control of transcription by the activators HIV Tat, c-myc, heat shock factor and hypoxia inducible factors.
描述(由申请人提供):通过RNA聚合酶I(pol II)调节转录来控制基因表达是细胞活力的基础,并且通常在疾病中被破坏。转录周期包括起始、延伸和终止阶段。这一建议侧重于后两个步骤,因为支配它们的机制不如启动机制那么清楚。我们的实验室使用联合收割机的策略,使突变的pol II和延伸因子的延长和终止在体内使用芽殖酵母和哺乳动物细胞的生化测定。终止是回收RNA聚合酶和防止相邻基因之间的干扰所必需的,但是触发在基因末端的极其稳定的转录延伸复合物的分解的机制还不完全清楚。我们将通过询问它如何受到pol II磷酸化和转录延伸率的影响来研究这种机制。我们还将通过两种方法寻找终止中的新参与者:1)基于我们对与终止因子Xrn 2(一种RNA核酸外切酶)相互作用的蛋白质因子的鉴定的候选方法; 2)对抑制终止的shRNA进行无偏倚的遗传筛选。 我们还将测试我们最近提出的一个模型,我们称之为“开盖和鱼雷”模型,用于通过过早终止来控制伸长。该模型表明,从大多数人类基因开始进入基因体的暂停位点的pol II的通量受到转录物脱帽和随后由Xrn 2和相关因子过早终止转录的限制。我们将测试这个模型的细节,并询问去帽和终止因子是否在转录周期的延伸阶段的调节中起作用。我们将集中在去帽和终止因子在控制转录的激活剂HIV达特,c-myc,热休克因子和缺氧诱导因子的潜在作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID L BENTLEY其他文献
DAVID L BENTLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID L BENTLEY', 18)}}的其他基金
Coupling of transcription elongation and termination with pre-mRNA processing
转录延伸和终止与前 mRNA 加工的耦合
- 批准号:
10559635 - 财政年份:2022
- 资助金额:
$ 30.98万 - 项目类别:
Coupling of transcription with nascent pre-mRNA metabolism
转录与新生前 mRNA 代谢的耦合
- 批准号:
9267500 - 财政年份:2016
- 资助金额:
$ 30.98万 - 项目类别:
Coupling of transcription with nascent pre-mRNA metabolism
转录与新生前体 mRNA 代谢的耦合
- 批准号:
9922320 - 财政年份:2016
- 资助金额:
$ 30.98万 - 项目类别:
Mis-regulation of mRNA poly (A) site selection in cancer cells (PQ11)
癌细胞中 mRNA Poly (A) 位点选择的错误调节 (PQ11)
- 批准号:
8515371 - 财政年份:2012
- 资助金额:
$ 30.98万 - 项目类别:
Mis-regulation of mRNA poly (A) site selection in cancer cells (PQ11)
癌细胞中 mRNA Poly (A) 位点选择的错误调节 (PQ11)
- 批准号:
8848048 - 财政年份:2012
- 资助金额:
$ 30.98万 - 项目类别:
Mis-regulation of mRNA poly (A) site selection in cancer cells (PQ11)
癌细胞中 mRNA Poly (A) 位点选择的错误调节 (PQ11)
- 批准号:
8676752 - 财政年份:2012
- 资助金额:
$ 30.98万 - 项目类别:
Elongation and termination of transcripts by RNA pol II
RNA pol II 转录本的延伸和终止
- 批准号:
7990815 - 财政年份:2009
- 资助金额:
$ 30.98万 - 项目类别:
Elongation and Termination of Transcripts by RNA Pol II
RNA Pol II 转录本的延伸和终止
- 批准号:
6687254 - 财政年份:2003
- 资助金额:
$ 30.98万 - 项目类别:
Elongation and Termination of Transcripts by RNA Pol II
RNA Pol II 转录本的延伸和终止
- 批准号:
7085486 - 财政年份:2003
- 资助金额:
$ 30.98万 - 项目类别:
Elongation and termination of transcripts by RNA pol II
RNA pol II 转录本的延伸和终止
- 批准号:
7578991 - 财政年份:2003
- 资助金额:
$ 30.98万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 30.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 30.98万 - 项目类别:
Standard Grant